Biocon Takes Its Oncology Biosimilars To 30 Countries In Africa And Asia
Enables Access To Trastuzumab And Pegfilgrastim Through Cancer Access Partnership
Indian company Biocon is aiming to “deliver substantial savings to healthcare systems” by enhancing access to and availability of oncology biosimilars in 25 countries in Africa and five countries in Asia, covered under the Cancer Access Partnership, led by the Clinton Health Access Initiative.
